The Annals Visit the PharmaCE website!
home help contact us subscription past issues search current issue
QUICK SEARCH:   [advanced]


     


Published Online, 9 October 2007, www.theannals.com, DOI 10.1345/aph.1K173.
 The Annals of Pharmacotherapy: Vol. 41, No. 11, pp. 1912-1914. DOI 10.1345/aph.1K173
© 2007 Harvey Whitney Books Company.
This Article
Right arrow Résumé Freely available
Right arrow Extracto Freely available
Right arrow Full Text
Right arrow PDF
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Articles Ahead of Print
Right arrow [Order Reprint]
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Huang, S.-S.
Right arrow Articles by Chiang, C.-E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Huang, S.-S.
Right arrow Articles by Chiang, C.-E.

Chitosan Potentiation of Warfarin Effect

Shao-Sung Huang, MD

Chief Resident, Division of Cardiology, Taipei Veterans General Hospital and National Yang-Ming University, Taipei, Taiwan

Shih-Hsien Sung, MD

Chief Resident, Division of Cardiology, Taipei Veterans General Hospital and National Yang-Ming University

Chern-En Chiang, MD PhD

Professor of Medicine, Division of Cardiology, Taipei Veterans General Hospital and National Yang-Ming University

Reprints: Dr. Chiang, Division of Cardiology, Taipei Veterans General Hospital, 201 Shih-Pai Rd., Sec. 2, Taipei 112, Taiwan, fax 886-2-2874-5422, cechiang{at}vghtpe.gov.tw

OBJECTIVE: To report a case in which the anticoagulation effect of warfarin appeared to have been potentiated by chitosan, probably due to interference with the absorption of vitamin K.

CASE SUMMARY: An 83-year-old male with hypertensive cardiovascular disease, type 2 diabetes mellitus, and chronic atrial fibrillation complicated by left atrial thrombus formation was maintained on warfarin 2.5 mg/day. Marked elevation of the international normalized ratio (INR) was noticed after self-medication with chitosan 1200 mg twice daily. He denied taking any other drugs, natural substances, herbal medicines, and nutritional supplements, and stated that he had not changed his dietary habits. After parenteral administration of vitamin K and discontinuation of chitosan, the INR returned to within the target range. However, the patient took chitosan again, and the INR increased to well above the target range. Following strong medical advice, the patient stopped taking chitosan, and the INR remained stable thereafter.

DISCUSSION: Chitosan is a positively charged polymer that binds to the negatively charged lipids and bile acids in the gastrointestinal tract. It can affect the absorption of vitamins A, D, E, and K. Therefore, the anticoagulation effect of warfarin may be potentiated by chitosan through this mechanism. Use of the Naranjo probability scale revealed that the adverse effect was probably due to chitosan.

CONCLUSIONS: The interaction between warfarin and chitosan has not previously been reported. Healthcare professionals should be aware of this potential interaction.

Key Words: chitosan, international normalized ratio, vitamin K, warfarin

Published Online, October 9, 2007. www.theannals.com, DOI 10.1345/aph.1K173




homecopy help contact us subscription past issues search current issue
Copyright © 2007 by Harvey Whitney Books Company.